Biosynthesized or biogenic metallic nanoparticles, particularly silver and gold nanoparticles
(AgNPs and AuNPs, respectively), have been increasingly used because of their …

Visceral leishmaniasis is a chronic parasitic disease associated with severe immune
dysfunction. Treatment options are limited to relatively toxic drugs, and there is no vaccine …

Leishmaniasis includes a spectrum of diseases ranging from debilitating cutaneous to fatal
visceral infections. This disease is caused by the parasitic protozoa of the genus Leishmania …

Leishmaniasis is one of the major health problems and categorized as a class I disease
(emerging and uncontrolled) by World Health Organization (WHO), causing highly …

Despite decades of research devoted to finding a vaccine against leishmaniasis, we are still
lacking a safe and effective vaccine for humans. Given this scenario, the search for a new …

Opinion statement Leishmaniasis, a protozoal infection transmitted by sandfly bite, produces
a clinical spectrum of disease ranging from asymptomatic infection to ulcerative skin and …

Introduction Leishmaniasis is a neglected tropical disease that is defined by the World
Health Organization as vaccine preventable. Although several new candidate vaccines are …

The control of diseases caused by protozoan parasites is one of the United Nations'
Sustainable Development Goals. In recent years much research effort has gone into …

Visceral leishmaniasis, caused by Leishmania donovani, L. infantum (syn. Leishmania
chagasi), is a globally widespread disease with a burden of about 400,000 new infections …

Visceral leishmaniasis (VL) is a fatal disease of the internal organs caused by the eukaryotic
parasite Leishmania. Control of VL would best be achieved through vaccination. However …